Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytosine arabinoside prodrug designed to bind plasma serum albumin for drug delivery

Published:2018-05-10 Issue:5 Volume:8 Page:1162-1170
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Wei Wei,He Zhonggui,Yang Jincheng,Sun Mengchi,Sun Jin

Funder

the National Basic Research Program of China

the innovation team project of education department of Liaoning province

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/article/10.1007/s13346-018-0534-4/fulltext.html

Reference28 articles.

1. Sun YB, Shi SL, Jing YK, Yin SL, Chen GL, Xu YJ, et al. Synthesis, transport and pharmacokinetics of 5′-amino acid ester prodrugs of 1-D-arabinofuranosylcytosine. Mol Pharm. 2008;6:315–25.

2. Liu YG, Dai QL, Wang SB, Deng QJ, Wu WG, Chen AZ. Preparation and in vitro antitumor effects of cytosine arabinoside-loaded genipin-poly-l-glutamic acid-modified bacterial magnetosomes. Int J Nanomedicine. 2015;10:1387–97.

3. Webster JA, Tibes R, Morris L, Blackford AL, Litzow M, Patnaik M, et al. Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leuk Res. 2017;61:108–16.

4. DeAngelis LM, Kreis W, Chan K, Dantis E, Akerman S. Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside. Cancer Chemother Pharmacol. 1992;29(3):173–7.

5. Hamada A, Kawaguchi T, Nakano M. Clinical pharmacokinetics of cytarabine formulations. Clin Pharmacokinet. 2002;41(10):705–18.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics;Journal of Controlled Release;2023-01

2. Current trends in the use of human serum albumin for drug delivery in cancer;Expert Opinion on Drug Delivery;2022-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3